Form 4: Alumis Inc. Executive Acquires Stock Options and Updates Beneficial Ownership

David M. Goldstein, Chief Scientific Officer of Alumis Inc., reports the acquisition of stock options and updates to his beneficial ownership of company stock.

Summary

• David M. Goldstein, the Chief Scientific Officer of Alumis Inc., filed a Form 4 detailing changes in his beneficial ownership.
• On February 18, 2025, Goldstein acquired stock options for 180,000 shares of Alumis Inc. at an exercise price of $5.06.
• These options vest over time, with 25% vesting on February 18, 2026, and the remainder vesting in equal monthly installments over the following 36 months, contingent on continuous service.
• Goldstein's holdings include 207,903 shares held by the Baily Goldstein Living Trust and 8,994 shares held by family members residing in his primary residence.
• An exempt gift transfer of 6,000 shares was made on November 26, 2024, from the Baily Goldstein Living Trust to family members.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock option grants. The vesting schedule suggests a long-term commitment.

Positives

• The acquisition of stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the stock options suggests a long-term commitment from the executive to the company's success.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.

Stakeholder Impact

• Shareholders can monitor insider transactions to gauge executive confidence in the company.
• Employees may be indirectly impacted by executive compensation structures.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Options, Alumis Inc., ALMS, Executive Compensation, David M. Goldstein